Safety question
Is Memantine (Namenda) safe?
Generally yes, with attention to dose and timing. Memantine (Namenda) scores 4/5. Adverse reactions are uncommon, minor, and reversible on stopping. The main risks are dose-related — starting at the low end of the clinical range and titrating up gives the best safety margin.
Safety score
4 / 5
Evidence grade
A
Severe reactions on file
0
Pubmed cites
4200
Key facts
- typical dose
- 5–20 mg
- dose frequency
- 1-2 doses
- timing
- AM/midday
- with food
- optional
- onset
- 180 minutes
- half-life
- 70 hours
- safety score
- 4/5
- evidence grade
- A
- class
- neuroprotective
- PubMed citations
- 4200
- legal status (US)
- Prescription-only
- legal status (UK)
- Prescription-only
- legal status (EU)
- Prescription-only
- legal status (AU)
- Prescription-only
- primary mechanism
- Uncompetitive NMDA receptor antagonist — blocks the NMDA channel only when it's pathologically over-activated, sparing normal signaling.
Common side effects
- Dizzinessmild
- Headachemild
Uncommon side effects
- Confusionmoderate
Who should not take Memantine (Namenda)
- Pregnant or breastfeeding individuals — most nootropics have not been adequately studied in pregnancy, and the precautionary principle applies.
- Anyone on a prescription medication that overlaps mechanistically (stimulants, SSRIs, MAOIs, beta-blockers, anticoagulants) — clear interactions with your prescribing clinician before adding Memantine (Namenda).
- Anyone with significant cardiovascular, hepatic, renal, or psychiatric disease — established conditions raise the baseline risk for any new compound.
- Minors — almost no nootropics have a paediatric safety record, and developing brains are differently sensitive.
What "safe" means here
Our safety scoring reflects (a) published clinical and observational literature on healthy-adult use at standard supplement doses, (b) the spectrum of adverse-event reports in the medical and supplement-pharmacovigilance record, and (c) the regulatory status across major jurisdictions. It does notreflect long-term outcomes in populations that haven’t been studied, and it does not substitute for clinical judgement applied to your individual situation.
A 5/5 score does not mean “no risk” — it means risk has been quantified as low in healthy adults at usual doses. Idiosyncratic and allergic reactions are possible with virtually any compound, including those we rate highest.
Full mechanism, citations, and dose guidance for Memantine (Namenda) are on the main reference page — see Memantine (Namenda). For the dose-by-dose breakdown, see Memantine (Namenda) dosage. To check stack interactions, use the interaction checker.
This page is informational. It is not medical advice and does not establish a clinician-patient relationship. Individual risk varies with genetics, medications, pre-existing conditions, and dose. Always consult a qualified clinician before starting a new compound. See our full disclaimer and terms.